Clinical characteristics and prognostic significance of DNA methylation regulatory gene mutations in acute myeloid leukemia
Abstract Background DNA methylation is a form of epigenetic modification that regulates gene expression. However, there are limited data on the comprehensive analysis of DNA methylation regulated gene mutations (DMRGM) in acute myeloid leukemia (AML) mainly referring to DNA methyltransferase 3α (DNM...
Main Authors: | Xiaoyan Xu, Hong Wang, Haohao Han, Yifang Yao, Xueqian Li, Jiaqian Qi, Chengsen Cai, Meng Zhou, Yaqiong Tang, Tingting Pan, Ziyan Zhang, Jingyi Yang, Depei Wu, Yue Han |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | Clinical Epigenetics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13148-023-01474-0 |
Similar Items
-
The Molecular Mechanisms of Resistance to IDH Inhibitors in Acute Myeloid Leukemia
by: Xiaomei Zhuang, et al.
Published: (2022-06-01) -
Emerging Targeted Therapy for Specific Genomic Abnormalities in Acute Myeloid Leukemia
by: Sung-Gi Chi, et al.
Published: (2022-02-01) -
From Bench to Bedside and Beyond: Therapeutic Scenario in Acute Myeloid Leukemia
by: Carmelo Gurnari, et al.
Published: (2020-02-01) -
Management of AML Beyond “3 + 7” in 2019
by: Jonathan Canaani
Published: (2019-03-01) -
Adverse Impact of DNA Methylation Regulatory Gene Mutations on the Prognosis of AML Patients in the 2017 ELN Favorable Risk Group, Particularly Those Defined by <i>NPM1</i> Mutation
by: James Yu, et al.
Published: (2021-05-01)